Dolex Children

Manufacturer: Pharmadel LLC
Effective date: 2020-08-06
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 23:26:47

Label at a glance#

ProductDolex Children

Active ingredientIBUPROFEN

Label structure9 sections

Indications and uses

temporarily: relieves minor aches and pains due to the common cold, flu, sore throat, headache and toothache reduces fever

Dosage and administration

this product does not contain directions or complete warnings for adult use do not give more than directed shake well before using mL = milliliter find right dose on chart. If possible, use weight to dose; otherwise use age. use only enclosed dosing cup. Do not use any other dosing device. if needed, repeat dose every 6-8 hours not use more than 4 times a day replace original bottle cap to maintain child resistanc...

Storage and handling

each 5 mL contains : sodium 2 mg store between 20-25°C (68-77°F) do not use if carton is opened or printed bottle neckband is broken or missing see bottom panel for lot number and expiration date

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact732-314-4550

Label contents#

Full prescribing information#

Drug Facts

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient & Purpose

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredient (in each 5 mL)	Purpose
Ibuprofen 100 mg (NSAID)*.......................................................	Pain reliever / fever reducer
*nonsteroidal anti-inflammatory

Warnings

WARNINGS SECTION

Allergy Alert:

SPL UNCLASSIFIED SECTION

Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

hives
facial swelling
asthma (wheezing)
shock
skin reddening
rash
blisters

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning:

SPL UNCLASSIFIED SECTION

This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if your child:

has had stomach ulcers or bleeding problems
takes a blood thinning (anticoagulant) or steroid drug
takes other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
takes more or for a longer time than directed

Heart attack and stroke warning:

SPL UNCLASSIFIED SECTION

NSAIDs, exceptaspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.

Sore throat warning:

SPL UNCLASSIFIED SECTION

Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult doctor promptly. Do not use more than 2 days or administer to children under 3 years of age unless directed by doctor.

Do not use

OTC - DO NOT USE SECTION

if the child has ever had an allergic reaction to Ibuprofen or any other pain reliever/fever reducer
right before or after heart surgery

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

stomach bleeding warning applies to your child
child has a history of stomach problems, such as heartburn
child has problems or serious side effects from taking
pain relievers or fever reducers
child has not been drinking fluids
child has lost a lot of fluid due to vomiting or diarrhea
child has high blood pressure, heart disease, liver
cirrhosis, kidney disease, or had a stroke
child has asthma
child is taking a diuretic

Ask a doctor or pharmacist before use if the child is

OTC - ASK DOCTOR/PHARMACIST SECTION

under a doctor's care for any serious condition
taking any other drug

When using this product

OTC - WHEN USING SECTION

take with food or milk if stomach upset occurs

Stop use and ask a doctor if

OTC - STOP USE SECTION

child experiences any of the following signs of stomach bleeding:
feels faint
vomits blood
has bloody or black stools
has stomach pain that does not get better
child has symptoms of heart problems or stroke:
chest pain
trouble breathing
weakness in one part or side of body
slurred speech
leg swelling
the child does not get any relief within first day (24 hours) of treatment
fever or pain gets worse or lasts more than 3 days
redness or swelling is present in the painful area
any new symptoms appear

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Uses

INDICATIONS & USAGE SECTION

temporarily:

relieves minor aches and pains due to the common cold, flu, sore throat, headache and toothache
reduces fever

Directions

DOSAGE & ADMINISTRATION SECTION

this product does not contain directions or complete warnings for adult use
do not give more than directed
shake well before using
mL = milliliter
find right dose on chart. If possible, use weight to dose; otherwise use age.
use only enclosed dosing cup. Do not use any other dosing device.
if needed, repeat dose every 6-8 hours not use more than 4 times a day
replace original bottle cap to maintain child resistance

Weight (lb)	Age (yr)	Dose (mL)*
under 24	under 2 years	ask a doctor
24-35 lbs	2-3 years	5 mL
36-47 lbs	4-5 years	7.5
48-59	6-8 years	10 mL
60-71 lbs	9-10 years	12.5 mL
72-95 lbs	11 years	15 mL

*or as directed by a doctor

Other information

STORAGE AND HANDLING SECTION

each 5 mL contains : sodium 2 mg
store between 20-25°C (68-77°F)
do not use if carton is opened or printed bottle neckband is broken or missing
see bottom panel for lot number and expiration date

Inactive ingredients

INACTIVE INGREDIENT SECTION

acesulfame potassium, anhydrous citric acid, carboxymethylcellulose sodium, D&C Yellow #10, FD&C Red #40, flavors, glycerin, microcrystalline cellulose, polysorbate 80, propylene glycol, purified water, sodium, benzoate, sucrose, and xanthan gum

Questions or comments?

OTC - QUESTIONS SECTION

Call 732-314-4550 from 9 AM to 5 PM EST, Monday – Friday

PACKAGE PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DOLEX CHILDREN

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
IBUPROFEN Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20191108

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
1e73f975-1ce7-705e-2bcf-788b1b5e24ba	Product name	5	20251124
16cde546-8deb-4df2-a072-dab5566ede95	Product name	1	20231003
f6d1b8d7-3bd1-4248-eddd-b60565c88015	Product name	4	20230808
874f4e63-49d2-5150-5d77-052172814ebd	Product name	6	20230105
557673c2-8256-b351-e863-4ec71a5a64b0	Product name	2	20160714
dbc9a339-6215-4e94-9546-57a3b34902ce	Product name	1	20160517
61c18d4e-b552-5478-8fc0-df38b93e3100	Product name	1	20140508
7b2938c9-7eb7-e312-ae90-f54f4240361e	Product name	1	20140508
997601aa-bb5f-6971-6b90-a21132c12c7b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
55758-304-04	Dolex Children	1 in 1 CARTON	LIQUID	1		1
55758-304-04	Dolex Children	118 mL in 1 BOTTLE	LIQUID	118		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55758-304	DOLEX CHILDREN (IBUPROFEN) LIQUID [PHARMADEL LLC]	1	Current NDC, Legacy NDC, 2 package rows	20200904_ac3c264f-da37-a474-e053-2a95a90abdad.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

Dolex Children
Ibuprofen
SUCROSE
ACESULFAME POTASSIUM
ANHYDROUS CITRIC ACID
D&C YELLOW NO. 10
CARBOXYMETHYLCELLULOSE SODIUM
XANTHAN GUM
CELLULOSE, MICROCRYSTALLINE
WATER
POLYSORBATE 80
PROPYLENE GLYCOL
SODIUM BENZOATE
GLYCERIN
FD&C RED NO. 40

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
55758-304	55758-304-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUCROSE	C151H8M554	IACT
ACESULFAME POTASSIUM	23OV73Q5G9	IACT
ANHYDROUS CITRIC ACID	XF417D3PSL	IACT
D&C YELLOW NO. 10	35SW5USQ3G	IACT
CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	IACT
XANTHAN GUM	TTV12P4NEE	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
WATER	059QF0KO0R	IACT
POLYSORBATE 80	6OZP39ZG8H	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
SODIUM BENZOATE	OJ245FE5EU	IACT
IBUPROFEN	WK2XYI10QM	ACTIB
GLYCERIN	PDC6A3C0OX	IACT
FD&C RED NO. 40	WZB9127XOA	IACT

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A210602-001	IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL			2018-11-23

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A210602-001	IBUPROFEN	100MG/5ML	SUSPENSION / ORAL	2018-11-23	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dolex Children	IBUPROFEN	Pharmadel LLC	ac3c264f-da37-a474-e053-2a95a90abdad	2020-08-06	Warnings	Exact identifier ndc (package): 55758-304-04 ndc (product): 55758-304 ndc11 (package): 55758030404 spl id: ac3c264f-da36-a474-e053-2a95a90abdad spl set id: ac3c264f-da37-a474-e053-2a95a90abdad

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.